Pharmaceuticals in biota

This dataset contains data that was collected for the HELCOM report on Pharmaceuticals in the Baltic sea (http://helcom.fi/Lists/Publications/BSEP149.pdf). UNESCO and HELCOM, 2017 (to be published). Status report on pharmaceuticals in the Baltic Sea region. Baltic Sea Environment Proceedings No. 149. Partly funded by Interreg Baltic Sea Region (EU Strategy support through Policy Area Hazards). Financial support was provided by Interreg Baltic Sea Region, United Nations Educational, Scientific and Cultural Organization (UNESCO) and Swedish International Development Cooperation Agency (SIDA). The report was prepared as a case study for the UNESCO-IHP International Initiative on Water Quality (IIWQ) UNESCO project: Emerging Pollutants in Wastewater Reuse in Developing Countries. Case Studies on Emerging Pollutants in Water and Wastewater. The dataset contains compound name, species, biota matrix, concentrations and whether compound has been detected in the sample. This dataset presents a compilation of concentrations and effects of pharmaceuticals in the Baltic Sea marine environment based on data collected by all Baltic Sea states via working groups of the Helsinki Commission, HELCOM. Data collected between the years 2003 to 2014, from coastal, open sea and transitional areas, was received from Denmark, Estonia, Finland, Germany, Poland and Sweden. • 4600 individual data posts were included in the complete data set • 167 different pharmaceuticals have been measured and 74 of these were found in at least one of the sampling matrices (water, sediment, biota) • 51 different pharmaceuticals have been detected in water (of 148 measured) • 9 different pharmaceuticals have been detected in sediment samples (of 25 measured) • 35 different pharmaceuticals have been detected in biota samples (of 116 measured) • Pharmaceuticals from all drug classes were detected See HELCOM BSEP 149 report chapter ”3. Data collection methodology and data availability” for further information.本数据集为波罗的海赫尔辛基委员会（HELCOM）《波罗的海地区药物状况报告》（http://helcom.fi/Lists/Publications/BSEP149.pdf）的配套采集原始数据，由联合国教育、科学及文化组织（UNESCO）与赫尔辛基委员会（HELCOM）于2017年编撰（待出版），收录于《波罗的海环境文集》（Baltic Sea Environment Proceedings）第149号。本项目部分由波罗的海地区跨境合作计划（Interreg Baltic Sea Region，即欧盟政策领域灾害相关战略支持项目）资助，此外还获得了波罗的海地区跨境合作计划、联合国教育、科学及文化组织（UNESCO）以及瑞典国际开发合作署（SIDA）的资金支持。本报告是联合国教科文组织水文计划（UNESCO-IHP）国际水质倡议（IIWQ）项目——“发展中国家废水回用中的新兴污染物”的案例研究成果，该项目主题为“水与废水中新兴污染物案例研究”。 本数据集包含化合物名称、物种、生物基质（biota matrix）、浓度数据，以及目标化合物是否在样本中被检出的信息。本数据集汇总了波罗的海沿岸各国通过赫尔辛基委员会（HELCOM）工作组采集的波罗的海海洋环境中药物的浓度与影响相关数据。 本次数据采集时间跨度为2003年至2014年，采样区域涵盖近岸、远海及过渡性海域，数据来源于丹麦、爱沙尼亚、芬兰、德国、波兰与瑞典六国。 • 完整数据集共纳入4600条独立数据记录 • 共检测到167种不同药物，其中74种至少在一种采样基质（水体、沉积物、生物群）中被检出 • 148种被测药物中，有51种在水体样本中被检出 • 25种被测药物中，有9种在沉积物样本中被检出 • 116种被测药物中，有35种在生物样本中被检出 • 所有药物类别均有检出物被发现 详细的数据采集方法与数据可用性说明，请参见赫尔辛基委员会（HELCOM）发布的《波罗的海环境文集》第149号报告第3章“数据采集方法与数据可用性”。